COVID-19 sent the restaurant industry into an unprecedented decline, but the CEO of the Union Square Hospitality Group, Danny Meyer, isn’t giving up on eating out. He’s keeping his teams motivated, making safety the new ambience, and taking his “culture-first” philosophy beyond the hospitality industry. Here’s what resilience looks like in the post-pandemic era.
Danny Meyer, Founder and CEO, Union Square Hospitality Group 
Interviewer: Dr. David B. Agus, USC

COVID-19 sent the restaurant industry into an unprecedented decline, but the CEO of the Union Square Hospitality Group, Danny Meyer, isn’t giving up on eating out. He’s keeping his teams motivated, making safety the new ambience, and taking his “culture-first” philosophy beyond the hospitality industry. Here’s what resilience looks like in the post-pandemic era.

A RECIPE FOR REBUILDING

The cascading crises of the past year have tested both the resiliency of the health care system and its social conscience. Gilead CEO Daniel O’Day joins us to discuss how his company pivoted and ushered through the approval of remdesivir, an antiviral now being used by roughly half of hospitalized coronavirus patients. We’ll also look beyond COVID-19, as Gilead continues the fight against cancer and HIV—with new treatments in the pipeline—and ongoing efforts to tackle racial and social justice. 
Daniel O’Day, Chairman and CEO, Gilead Sciences, Inc.

The cascading crises of the past year have tested both the resiliency of the health care system and its social conscience. Gilead CEO Daniel O’Day joins us to discuss how his company pivoted and ushered through the approval of remdesivir, an antiviral now being used by roughly half of hospitalized coronavirus patients. We’ll also look beyond COVID-19, as Gilead continues the fight against cancer and HIV—with new treatments in the pipeline—and ongoing efforts to tackle racial and social justice.

BEYOND COVID: TACKLING CANCER, HIV AND SOCIAL EQUITY

Hosted by IBM Watson Health
At the intersection of healthcare, economics, and equity, we find the key to keeping our communities healthy: a great hospital. The Fortune/IBM Watson Health 100 Top Hospitals List ranks institutions based on outcome, patient experience, and more. And, for the first time this year, we’ve added an incredibly important factor that has long been overlooked: how hospitals serve the broader community around them. Join us for a candid exploration into how we can revolutionize community health in the 21st century. 
Dr. Irene Dankwa-Mullan, Deputy Chief Health Officer and Chief Health Equity Officer, IBM Watson Health 
Jayne Pope, Chief Executive Officer, Hill Country Memorial 
Dr. Joshua Sharfstein, Vice Dean, Public Health Practice and Community Engagement, Johns Hopkins Bloomberg School of Public Health 
Dr. Rachel Thornton, Associate Professor, John Hopkins School of Medicine and Associate Director for Policy, Johns Hopkins Center for Health Equity 
Moderator: Clifton Leaf, Editor-in-Chief, FORTUNE; Co-chair, Fortune Brainstorm Health<br

At the intersection of healthcare, economics, and equity, we find the key to keeping our communities healthy: a great hospital. The Fortune/IBM Watson Health 100 Top Hospitals List ranks institutions based on outcome, patient experience, and more. And, for the first time this year, we’ve added an incredibly important factor that has long been overlooked: how hospitals serve the broader community around them. Join us for a candid exploration into how we can revolutionize community health in the 21st century.

BREAKOUT SESSION: THE 100 TOP HOSPITALS: THE CORE OF COMMUNITY HEALTH

COVID-19 has caused immense suffering throughout the world, but it has also provided us with some hard-earned lessons. Over the next two days, we’ll explore the key innovations and inspirational collaborations that have emerged during the past year—and examine the lessons that ought to stick with us if we’re smart. The fundamental question for us all: How can we build resilience into a health care system that has been strained to the breaking point? And how can we make ourselves more resilient in the process? 
Dr. David B. Agus, Professor of Medicine and Engineering, Keck School of Medicine and Viterbi School of Engineering; Chief Executive Officer, Ellison Institute, University of Southern California; Co-chair, Fortune Brainstorm Health 
Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health 
Clifton Leaf, Editor-in-Chief, FORTUNE; Co-chair, Fortune Brainstorm Health

BUILDING RESILIENCE

If the past year taught us nothing else, it might be that change is the only constant in life. So then, how can we learn to reinvent ourselves in times of transition? Author and the inspiration for NBC's Council of Dads Bruce Feiler believes our ability to adapt is our most powerful skill. In collecting hundreds of life stories, he shares what he says are the biggest roadblocks to resilience as well as the secrets to being creative in moments of uncertainty. A master class on what it takes to be resilient and how to thrive when faced with change. 
Bruce Feiler, Author, Life is in the Transitions

If the past year taught us nothing else, it might be that change is the only constant in life. So then, how can we learn to reinvent ourselves in times of transition? A master class on what it takes to be resilient and how to thrive when faced with change

BUILDING RESILIENCE IN OURSELVES

The rapid innovation and collaboration that has defined the effort to create COVID-19 vaccines has opened an important door: offering a new approach to treating cancer. Both Moderna and Pfizer/BioNTech say their coronavirus vaccines have shown how mRNA-based medicines can not only target viruses, but also malignant tumors with remarkable safety and specificity. We sit down with Moderna CEO Stéphane Bancel to find out what’s on the horizon and how RNA-based drugs offer a genetic blueprint for beating cancer. 
Stéphane Bancel, Chief Executive Officer, Moderna 
Interviewer: Clifton Leaf, FORTUNE

The rapid innovation and collaboration that has defined the effort to create COVID-19 vaccines has opened an important door: offering a new approach to treating cancer. Both Moderna and Pfizer/BioNTech say their coronavirus vaccines have shown how mRNA-based medicines can not only target viruses, but also malignant tumors with remarkable safety and specificity. We sit down with Moderna CEO Stéphane Bancel to find out what’s on the horizon and how RNA-based drugs offer a genetic blueprint for beating cancer.

COULD mRNA BE THE SECRET WEAPON AGAINST BOTH COVID AND CANCER?

What to teach a new generation of public health officials to help us prevent the next pandemic—or at least thrive better in it. 
Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine
Dr. Michelle Williams, Dean of the Faculty, T.H. Chan School of Public Health, Harvard University 
Moderator: Arianna Huffington, Thrive Global

What to teach a new generation of public health officials to help us prevent the next pandemic—or at least thrive better in it.

DEAN’S LIST: BRINGING THE LESSONS OF COVID-19 INTO THE CLASSROOM

Calling Dr. Churchwell...but which one, you might ask? Meet three brothers—Dr. Kevin Churchwell (President and CEO of Boston Children’s Hospital), Dr. Keith Churchwell (President of Yale New Haven Hospital), and Dr. André Churchwell (Vice Chancellor and Chief Diversity Officer for Vanderbilt University)—who have tripled-down on saving lives and driving social change. They follow in the footsteps of their father, Robert Churchwell, who was dubbed “the Jackie Robinson of Journalism” after becoming one of the first black journalists to be employed at a white-owned, Southern metropolitan newspaper. A conversation about inclusiveness (and our failure to achieve it) that will open your eyes as never before. 
Dr. André Churchwell, Vice Chancellor, Equity, Diversity and Inclusion, and Chief Diversity Officer, Vanderbilt University 
Dr. Keith Churchwell, President, Yale New Haven Hospital 
Dr. Kevin Churchwell, President and CEO, Boston Children’s Hospital 
Moderator: Michal Lev-Ram, FORTUNE

Meet three brothers—Dr. Kevin Churchwell, Dr. Keith Churchwell, and Dr. André Churchwell—who have tripled-down on saving lives and driving social change. A conversation about inclusiveness (and our failure to achieve it) that will open your eyes as never before.

FAMILY TIES: BROTHERS IN SOCIAL CHANGE DRIVING INCLUSIVITY IN MEDICINE

COVID-19 has brought the world together in a way history has rarely seen. As we navigate the virus globally, the race for immunization has created a web among countries. Johnson & Johnson made headlines for pledging to distribute hundreds of millions of vaccine doses to the African Union, opening a conversation about vaccine accessibility on both a community and global level. When speaking at Brainstorm Health last year, J&J CEO Alex Gorsky characterized the COVID-19 vaccine development process as a moonshot. We take a look back at a year that set out to achieve the unbelievable. 
Alex Gorsky, Chairman and CEO, Johnson & Johnson 
Interviewer: Dr. David B. Agus, USC

COVID-19 has brought the world together in a way history has rarely seen. As we navigate the virus globally, the race for immunization has created a web among countries. Johnson &amp; Johnson made headlines for pledging to distribute hundreds of millions of vaccine doses to the African Union, opening a conversation about vaccine accessibility on both a community and global level. We take a look back at a year that set out to achieve the unbelievable.

FROM MOONSHOT TO REALITY

Consumer health data has never been more accessible—or plentiful, with a reported increase of nearly 900% since just 2016. But buried in this deluge are big questions: how do you make sense of all these bits and bytes and who owns the data? As consumer health data becomes more accessible -- from health and fitness apps, genetic health reports and EHRs -- how do we address potential issues of privacy, consent, and legal protection? An exploration into how this data can be managed and when it can be used in order to tap into the enormous value stored within. 
Dr. Gretchen Jackson, Vice President and Chief Science Officer, IBM Watson Health 
Anne Wojcicki, Co-founder and CEO, 23andMe 
Moderator: Clifton Leaf, FORTUNE

Consumer health data has never been more accessible—or plentiful, with a reported increase of nearly 900% since just 2016. But buried in this deluge are big questions: how do you make sense of all these bits and bytes and who owns the data? As consumer health data becomes more accessible—from health and fitness apps, genetic health reports and EHRs—how do we address potential issues of privacy, consent, and legal protection?

HEALTH DATA DELUGE: THE PROMISES AND POTENTIAL PITFALLS

For decades, disparities in care have plagued our health care system and the COVID-19 pandemic thrust these divisions under a national spotlight. For underserved communities, there’s still much work to be done when it comes to the affordability of and access to care. A conversation with the CEO of the nation’s largest integrated health system, Greg Adams, and Intermountain Health CEO Dr. Marc Harrison, to address how the industry can improve community health and affect change at a systematic level. 
Greg Adams, Chair and CEO, Kaiser Permanente
Dr. Marc Harrison, President and CEO, Intermountain Health 
Moderator: Dr. David B. Agus, USC

For decades, disparities in care have plagued our health care system and the COVID-19 pandemic thrust these divisions under a national spotlight. For underserved communities, there’s still much work to be done when it comes to the affordability of and access to care. A conversation with the CEO of the nation’s largest integrated health system, Greg Adams and Intermountain Health CEO Dr. Marc Harrison will address how the industry can improve community health and affect change at a systematic level.

HEALTH EQUITY: WHY IT MATTERS AND HOW WE GET THERE

After a year of lightning fast vaccine development and rollout, there’s even more hope on the horizon. Pfizer and BioNTech recently reported their COVID-19 vaccine to be 100 percent effective for teens aged 12 to 15, raising the possibility for a full-time return to school for more of this nation’s children. In this 1-on-1, Pfizer CEO Dr. Albert Bourla shares how his company survived a year of immense change and pressure, how science won the day and what this race to the finish means to him. A candid conversation about resilience, both professional and personal, with this son of Holocaust survivors. 
Dr. Albert Bourla, Chairman and CEO, Pfizer 
Interviewer: Dr. David B. Agus, USC

After a year of lightning fast vaccine development and rollout, there’s even more hope on the horizon. Pfizer and BioNTech recently reported their COVID-19 vaccine to be 100 percent effective for teens aged 12 to 15, raising the possibility for a full-time return to school for more of this nation’s children. In this 1-on-1, Pfizer CEO Dr. Albert Bourla shares how his company survived a year of immense change and pressure, how science won the day and what this race to the finish means to him.

HOW SCIENCE DEFIED THE ODDS

Call it the great turning point. For millions of us, remote working has gone from novel idea to everyday reality, private domains become crowded workspaces, and close collaborations happen through small windows on our computer screens and phones. For all of the virtual face time, we’ve lost critical face-to-face time. And that has presented all of us with a profound set of challenges as “work” returns to its new normal. The good news: it’s also a chance for leaders across the business realm to define a healthier normal. Some insights for supporting the physical and mental well-being of our returning corporate families. 
Deborah DiSanzo, President, Best Buy Health 
Deborah Majoras, Chief Legal Officer and Secretary, The Procter & Gamble Company 
Moderator: Arianna Huffington, Thrive Global

For millions of us, remote working has gone from novel idea to everyday reality, private domains become crowded workspaces, and close collaborations happen through small windows on our computer screens and phones. For all of the virtual face time, we’ve lost critical face-to-face time. And that has presented all of us with a profound set of challenges as “work” returns to its new normal. The good news: it’s also a chance for leaders across the business realm to define a healthier normal.

HOW TO SUPPORT A MORE RESILIENT WORKFORCE

Fortifying a community requires investment—of money, human capital, and time. So where are the smart investments headed after a year of pandemic? While health care stocks underperformed the broader market in 2020 and sectors like elective surgery and medical devices took a hit, there was also the promise of vaccine development and the skyrocketing usage of telemedicine. What’s on the horizon for 2021 and beyond—and where we have not just the opportunity, but the responsibility to invest going forward. 
Vinod Khosla, Founder, Khosla Ventures 
Interviewer: Christina Farr, Health Tech Investor, OMERS Ventures

Fortifying a community requires investment—of money, human capital, and time. So where are the smart investments headed after a year of pandemic? While health care stocks underperformed the broader market in 2020 and sectors like elective surgery and medical devices took a hit, there was also the promise of vaccine development and the skyrocketing usage of telemedicine. What’s on the horizon for 2021 and beyond—and where we have not just the opportunity, but the responsibility to invest going forward.

INVESTING IN RESILIENCE

Tara Stiles, Founder, Stråla Yoga

MENTAL HEALTH BREAK: INTENTION SETTING MEDITATION

Tara Stiles, Stråla Yoga

MENTAL HEALTH BREAK: MOVEMENT BREAK

NETWORKING BREAK

The health care landscape was changing rapidly before COVID-19. The pandemic sped up that transformation to warp level. From fast-evolving supply chains to virtual office visits to an unprecedented acceleration in the process for drug development, the lessons of 2020 are reshaping 2021 and beyond. We sit down with top leaders to address how they are pivoting their businesses to become more resilient in a time of sea change. 
Robert Ford, President and CEO, Abbott 
Mike Kaufmann, Chief Executive Officer, Cardinal Health 
Interviewer: Michal Lev-Ram, Editorial Director, Fortune Live Media; Senior Writer, FORTUNE

The health care landscape was changing rapidly before COVID-19. The pandemic sped up that transformation to warp level. From fast-evolving supply chains to virtual office visits to an unprecedented acceleration in the process for drug development, the lessons of 2020 are reshaping 2021 and beyond. We sit down with top leaders to address how they are pivoting their businesses to become more resilient in a time of sea change.

PIVOTING IN A PANDEMIC: HOW TO ADAPT A BUSINESS IN THE MIDST OF A STORM

Let us state an uncomfortable fact: every patient journey is an unwanted one. But how can we make that experience less agonizing, less confusing, and less traumatic? How do we transform from within to make sure that journey is at least headed to the right destination—with fewer detours, delays, and disappointments along the way? It is the great quest for health care leaders and policymakers everywhere to ensure the interest of the patient always comes first. We are lucky enough to sit down with one of the most thoughtful in the realm, Mayo Clinic CEO Dr. Gianrico Farrugia. 
Dr. Gianrico Farrugia, President and CEO, Mayo Clinic 
Interviewer: Clifton Leaf, FORTUNE

Let us state an uncomfortable fact: every patient journey is an unwanted one. But how can we make that experience less agonizing, less confusing, and less traumatic? How do we transform from within to make sure that journey is at least headed to the right destination—with fewer detours, delays, and disappointments along the way?

REENGINEERING THE PATIENT JOURNEY

Dr. Frances Arnold turned bioengineering upside down and became the first American woman to win a Nobel Prize in chemistry. But being recognized for her use of directed evolution to engineer enzymes is neither the beginning, nor the end, of her story. The Nobel Laureate and now co-chair of President Biden’s Council of Advisors on Science and Technology shares about her groundbreaking work, how her life has changed since being recognized, and how science can shape policy to face the challenges of the future. 
Dr. Frances Arnold, Linus Pauling Professor, California Institute of Technology; Nobel Prize Laureate 
Interviewer: Sue Siegel, Board Member, Illumina, Align, KFF, and MIT The Engine

Dr. Frances Arnold turned bioengineering upside down and became the first American woman to win a Nobel Prize in chemistry. The Nobel Laureate and now co-chair of President Biden’s Council of Advisors on Science and Technology shares about her groundbreaking work, how her life has changed since being recognized, and how science can shape policy to face the challenges of the future.

RESILIENCE DEFINED

Musicians know it instinctively: Improvisation is itself the art of resiliency. But can we apply the same art for coping with crisis? Can music help us turn life’s harshest tones into melodies? As both Artistic Director of Jazz At Lincoln Center and an internationally-acclaimed musician, composer, educator, and author, Wynton Marsalis has been dealing with the pandemic from all sides. A conversation about how the art of improvisation can help us keep moving forward. 
Wynton Marsalis, Trumpeter, Band Leader and Composer; Managing and ​Artistic Director, Jazz at Lincoln Center 
Interviewer: Ellen McGirt, Senior Editor, FORTUNE

Musicians know it instinctively: Improvisation is itself the art of resiliency. But can we apply the same art for coping with crisis? Can music help us turn life’s harshest tones into melodies? As both Artistic Director of Jazz At Lincoln Center and an internationally-acclaimed musician, composer, educator, and author, Wynton Marsalis has been dealing with the pandemic from all sides. A conversation about how the art of improvisation can help us keep moving forward.

RESILIENCY FOR THE SOUL: THE POWER OF MUSIC TO HEAL AND SUSTAIN

When it comes to feeding the world, the challenges are broad and this past year has shown just how fragile our food systems are. We sit down with two leaders who are attacking the big problems with big data: one who’s using A.I. to forecast demand for commodities around the world, another who’s building a more stable food supply for the generations to come. How data can feed the world. 
Sonia Lo, Chief Executive Officer, Sensei Ag 
Sara Menker, Founder and CEO, Gro Intelligence 
Moderator: Beth Kowitt, Senior Editor, FORTUNE

When it comes to feeding the world, the challenges are broad and this past year has shown just how fragile our food systems are. We sit down with two leaders who are attacking the big problems with big data: one who’s using A.I. to forecast demand for commodities around the world, another who’s building a more stable food supply for the generations to come. How data can feed the world.

REVOLUTIONIZING THE FUTURE OF FOOD: HOW BIG DATA CAN TRANSFORM OUR HEALTH AND OUR CLIMAT

SESSION TO BE ANNOUNCED

Motivated by frustration and helplessness with the nation’s health care system in her own childhood loss, Karen S. Lynch built her career around fixing a broken system. She took the helm at one of the world’s largest healthcare companies just this year after leading the CVS Health COVID-19 response from the start of the pandemic. Now she’s set her sights on improving access to affordable health care while transitioning the business to a broader health services company. A candid one-on-one. 
Karen S. Lynch, President and CEO, CVS Health 
Interviewer: Arianna Huffington, Thrive Global

Motivated by frustration and helplessness with the nation’s health care system in her own childhood loss, Karen S. Lynch built her career around fixing a broken system. She took the helm at one of the world’s largest healthcare companies just this year after leading the CVS Health COVID-19 response from the start of the pandemic. Now she’s set her sights on improving access to affordable health care while transitioning the business to a broader health services company.

SOLVING THE LAST MILE

As the entire world faces off against an insidious globetrotting virus, our focus has drifted away from the chronic, non-communicable health issues that affect millions of people and cost untold billions of dollars a year to treat. From cancer to diabetes to depression, a quiet shadow epidemic of disease is looming. Yes, we are all anxious to put COVID-19 in the rearview mirror. But here’s what we must consider when it comes to treating, or hopefully preventing, the pathologies that await us on the road ahead. 
Robert Bradway, Chairman and CEO, Amgen 
Dr. Margaret Hamburg, Vice President, Global Biological Policy and Programs, Nuclear Threat Initiative 
Moderator: Dr. Michelle McMurry-Heath, President and CEO, Biotechnology Innovation Organization

As the entire world faces off against an insidious globetrotting virus, our focus has drifted away from the chronic, non-communicable health issues that affect millions of people and cost untold billions of dollars a year to treat. From cancer to diabetes to depression, a quiet shadow epidemic of disease is looming. Yes, we are all anxious to put COVID-19 in the rearview mirror. But here’s what we must consider when it comes to treating, or hopefully preventing, the pathologies that await us on the road ahead.

TACKLING THE SECONDARY HEALTH CRISIS

One thing this extraordinary year has taught us: We have the data. We have the science. We have the passion. And we have the brilliance needed to solve a whole host of problems. So where are the gaps blocking us from solving so many of these challenges? The answer: leadership. While strong leaders made so much possible this past year—from rapid vaccine discovery and rollout to enabling millions to work effectively from home—there is still a world of problems that needs fixing. A conversation with two leading CEOs on resilience, leading through crisis, and collaborating at scale. 
Gail Boudreaux, President and CEO, Anthem, Inc. 
Julie Sweet, Chief Executive Officer, Accenture 
Moderator: Arianna Huffington, Thrive Global

One thing this extraordinary year has taught us: We have the data. We have the science. We have the passion. And we have the brilliance needed to solve a whole host of problems. So where are the gaps blocking us from solving so many of these challenges? The answer: leadership. While strong leaders made so much possible this past year—from rapid vaccine discovery and rollout to enabling millions to work effectively from home—there is still a world of problems that needs fixing.

THE LEADERSHIP CHALLENGE: COLLABORATION AT SCALE

The global COVID-19 pandemic has tested leadership like few other events in recent history. CEOs, elected officials, and top brass everywhere have found themselves at a turning point: The most successful ones understand how to drive the mission toward the organization’s purpose while making every stakeholder feel a part of it. We are joined by two powerful guides in this quest—one from business and the other from the military. We’ll explore how leaders can rewrite the playbook, and embrace their missions with drive, empathy, and humanity. 
Hubert Joly, Senior Lecturer, Harvard Business School; Former Chairman and CEO, Best Buy 
Ltg (ret.) Nadja West, 44th Army Surgeon General; Former Commanding General, U.S. Army Medical Command 
Interviewer: Alan Murray, Chief Executive Officer, FORTUNE

The global COVID-19 pandemic has tested leadership like few other events in recent history. CEOs, elected officials, and top brass everywhere have found themselves at a turning point: The most successful ones understand how to drive the mission toward the organization’s purpose while making every stakeholder feel a part of it. We are joined by two powerful guides in this quest—one from business and the other from the military.

THE LEADERSHIP CHALLENGE: PUTTING PEOPLE AND PURPOSE FIRST

Quantum computing may offer us a revolutionary opportunity to solve the most intractable problems in healthcare. Tapping into the mysterious power of the atom may one day help us achieve pinpoint diagnoses, discover new drugs with breakneck speed, and even solve some of the biggest puzzles of healthcare economics. Join us as we explore how the incorporation of quantum computers can propel healthcare forward. 
Dr. Darío Gil, Senior Vice President and Director, IBM Research 
Dr. Tomislav Mihaljevic, President and CEO, Cleveland Clinic 
Moderator: Robert Hackett, Senior Writer, FORTUNE

Quantum computing may offer us a revolutionary opportunity to solve the most intractable problems in healthcare. Tapping into the mysterious power of the atom may one day help us achieve pinpoint diagnoses, discover new drugs with breakneck speed, and even solve some of the biggest puzzles of healthcare economics.

THE QUBIT QUEST: CAN QUANTUM COMPUTING SOLVE OUR MOST COMPLEX HEALTHCARE CHALLENGES?

Zoom has more than 300 million daily participants. And one of those is Eric Yuan, the company’s CEO who no surprise does all of his meetings on, you guessed it, Zoom. (He was a virtual meeting guy before the pandemic too.) So Fortune Brainstorm Health thought we would go right to the source for a bunch of critical questions. What’s the cure for Zoom fatigue? How do we regain human contact in a sea of tiny virtual windows? And is anybody still wearing pants to work? 
Eric Yuan, Founder and CEO, Zoom 
Interviewer: Dr. David B. Agus, USC

Zoom has more than 300 million daily participants. And one of those is Eric Yuan, the company’s CEO who no surprise does all of his meetings on, you guessed it, Zoom.  What’s the cure for Zoom fatigue? How do we regain human contact in a sea of tiny virtual windows? And is anybody still wearing pants to work?

THIS IS YOUR BRAIN ON SCREEN

TRANSITION BREAK

Oscar Munoz knows a lot about bouncing back. When the vegan triathlete required a heart transplant shortly after taking the reins at United, it was a shock to the system. After his own recovery, he turned around what had been a struggling and divided airline. Now, with the COVID-19 pandemic having grounded flights on an unprecedented global scale and the travel industry facing uncertainty about when business will return, he is applying the same resilience to the future of his industry.	 
Oscar Munoz, Executive Chairman, United Airlines Holdings, Inc. 
Interviewer: Arianna Huffington, Thrive Global

Oscar Munoz knows a lot about bouncing back. When the vegan triathlete required a heart transplant shortly after taking the reins at United, it was a shock to the system. After his own recovery, he turned around what had been a struggling and divided airline. Now, with the COVID-19 pandemic having grounded flights on an unprecedented global scale and the travel industry facing uncertainty about when business will return, he is applying the same resilience to the future of his industry.

UP IN THE AIR: RESILIENCY RISING

COVID-19 shined a glaring spotlight on an issue we knew was there but is now impossible to ignore: only 5% of active physicians in the U.S. are Black, and fewer than 6% are Hispanic. With the virus ravaging communities of color disproportionately, and with vaccine distribution lagging among these same groups, it’s clear that rebuilding trust between the medical community and communities of color is paramount. Step one: bring more doctors of color into the pipeline. Join us for this extraordinary spoken-word performance, followed by a conversation with Dr. Chika Stacy Oriuwa. 
Dr. Chika Stacy Oriuwa, Resident Physician, University of Toronto Department of Psychiatry 
Interviewer: Dr. Michelle Williams, Dean of the Faculty, Harvard T.H. Chan School of Public Health

WE HAVE A DIVERSITY PROBLEM IN MEDICINE. HERE’S HOW TO FIX IT.

WELCOME

Hosted by Komodo Health 

From the earliest days of the COVID-19 vaccine rollout this winter, one immediate challenge became apparent: inequity in distribution. When it comes to COVID-19, Black, Latino and Native Americans (many of whom are also frontline workers) have higher rates of infection, hospitalization and death than their relative proportion of the population. At the same time, these same populations are being vaccinated against the virus at lower rates. In this discussion in partnership with Komodo Health, leading experts will share why and where certain communities are underserved, how to combat vaccine skepticism and how we can best use lessons from our healthcare history to achieve more equitable vaccination efforts going forward. 
Dr. Karen DeSalvo, Chief Health Officer, Google Health 
Dr. Bon Ku, The Marta and Robert Professor of Medicine and Design, Thomas Jefferson University 
Dr. Arif Nathoo, Co-founder and CEO, Komodo Health 
Dr. Ala Stanford, Pediatric Surgeon; Founder, The Black Doctors COVID19 Consortium 
Moderator: Clifton Leaf, FORTUNE

Hosted by Komodo Health
From the earliest days of the COVID-19 vaccine rollout this winter, one immediate challenge became apparent: inequity in distribution. When it comes to COVID-19, Black, Latino and Native Americans (many of whom are also frontline workers) have higher rates of infection, hospitalization and death than their relative proportion of the population. At the same time, these same populations are being vaccinated against the virus at lower rates. Leading experts will share why and where certain communities are underserved, how to combat vaccine skepticism and how we can best use lessons from our healthcare history to achieve more equitable vaccination efforts going forward.

BREAKOUT SESSION: A SHOT OF EQUITY

Hosted by Salesforce 
Now’s your chance to steal that coveted coffee mug in the company kitchen. That’s because many of your colleagues won’t be returning to the office this year. As vaccines roll out and water cooler chatter hums about a “return to normal,” we’re likely to see a new phenomenon take place: a hybrid workforce that blends remote colleagues with those working side-by-side. For companies large and small, this will require introducing some new and adaptive ways of collaborating, idea-generating, and boosting morale. In this conversation in partnership with Salesforce, we take these challenges—from reskilling to workplace safety to onboarding new employees and ultimately, to building a mentally and emotionally resilient workforce—head on. A discussion on how creativity and innovation can support this once-in-a-lifetime workplace pivot. 
Maria Dee, Executive Director, Workforce Wellbeing, Kaiser Permanente 
Dr. Pamela Hymel, Chief Medical Officer, Disney Parks, Experiences and Products 
Francine Katsoudas, Executive Vice President and Chief People, Policy and Purpose Officer, Cisco 
Additional speakers to be announced 
Moderator: Arianna Huffington, Thrive Global

Hosted by Salesforce
As vaccines roll out and water cooler chatter hums about a “return to normal,” we’re likely to see a new phenomenon take place: a hybrid workforce that blends remote colleagues with those working side-by-side. For companies large and small, this will require introducing some new and adaptive ways of collaborating, idea-generating, and boosting morale. In this conversation  we take these challenges—from reskilling to workplace safety to onboarding new employees and ultimately, to building a mentally and emotionally resilient workforce—head on. A discussion on how creativity and innovation can support this once-in-a-lifetime workplace pivot.

BREAKOUT SESSION: C-SUITE PERSPECTIVES: REIMAGINING A HEALTHIER AND MORE CONNECTED WORKPLACE

Join the Brainstorm Health community-- a powerful gathering of leaders at the crossroads of business, health care, technology, and innovation.

FORTUNE Brainstorm Health Virtual

The FORTUNE CFO Collaborative

CLOSING MAINSTAGE SESSION

INTERMISSION

LEADERSHIP ROUNDTABLES

MAINSTAGE SESSION

NETWORKING

OPENING MAINSTAGE SESSION

STRATEGY SESSIONS

The FORTUNE Global Forum is virtual. We will bring together the leaders of the world’s biggest corporations–the FORTUNE Global 500–with innovators, builders, and other selected experts to explore the key issues shaping global business

Upcoming Conferences

FORTUNE Brainstorm Health Virtual

APRIL 27-28, 2021 | Virtual

Alex Gorsky

Gail Boudreaux

Karen S. Lynch

Wynton Marsalis

The FORTUNE CFO Collaborative

MAY 11, 2021

FORTUNE Global Forum VIRTUAL

JUNE 08-09, 2021 | Virtual